NATIXIS ADVISORS, L.P. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$648
+54.3%
23,793
+26.1%
0.00%
+100.0%
Q2 2023$420
-5.4%
18,872
-7.9%
0.00%
-50.0%
Q1 2023$444
+48.0%
20,487
+38.6%
0.00%
+100.0%
Q4 2022$300
-99.9%
14,777
-21.8%
0.00%
-50.0%
Q3 2022$485,000
+23.7%
18,900
+14.5%
0.00%0.0%
Q2 2022$392,000
-6.2%
16,500
-11.2%
0.00%0.0%
Q1 2022$418,000
+77.9%
18,581
+56.7%
0.00%
+100.0%
Q4 2021$235,00011,8550.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders